Systematic Screening of Oil, Surfactant, and Cosurfactant for Ibuprofen Nanoemulsion
Abstract
Ibuprofen, a widely used non-steroidal anti-inflammatory drug (NSAID), provides effective symptomatic relief; however, its oral administration is often associated with systemic side effects. Topical delivery via nanoemulsion systems offers a promising strategy to enhance local bioavailability while minimizing systemic exposure. This study aimed to systematically screen and identify optimal oil, surfactant, and cosurfactant components for ibuprofen nanoemulsion formulations. Ibuprofen solubility was assessed in various oils, followed by screening surfactants and cosurfactants based on emulsification efficiency, drug-loading capacity, and compatibility. Nanoemulsions were prepared using high-energy sonication methods and characterized for droplet size, polydispersity index (PDI), drug loading, and physical stability over 30 days. Capryol 90 exhibited the highest solubility for ibuprofen (103.01 ± 0.53 mg/mL), while Kolliphor RH 40 produced nanoemulsions with the smallest droplet size (109.7 ± 56.9 nm) and lowest PDI (0.214 ± 0.02). Transcutol P enabled the highest drug loading (280 mg/mL) and supported formulation stability. Ultrasonic bath sonication resulted in smaller, more uniform droplets than homogenizer sonication, and the optimized nanoemulsion maintained its droplet size and PDI throughout 30 days of storage. These results provide a preliminary basis for excipient selection in ibuprofen nanoemulsion development and suggest the potential for developing a stable topical delivery.
Keywords
Supporting Institution
Thanks
References
- 1. Zobdeh F, Eremenko II, Akan MA, Tarasov V V., Chubarev VN, Schiöth HB, et al. Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. Pharmaceutics [Internet]. 2022;14(6). Available from:
. - 2. Milanowski B, Wosicka-Frąckowiak H, Główka E, Sosnowska M, Woźny S, Stachowiak F, et al. Optimization and evaluation of the in vitro permeation parameters of topical products with non-steroidal anti-inflammatory drugs through strat-m® membrane. Pharmaceutics [Internet]. 2021;13(8). Available from:
. - 3. Hawthorn C. A Narrative Review: The Use of the Topical NSAID Ibuprofen for the Treatment of Knee Osteoarthritis. Supporting Clinician Decision-Making in the First-Line Treatment of Osteoarthritis. Rehabil Process Outcome [Internet]. 2020;(9):1–8. Available from:
. - 4. Rathore C, Hemrajani C, Sharma AK, Gupta PK, Jha NK, Aljabali AAA, et al. Self-nanoemulsifying drug delivery system (SNEDDS) mediated improved oral bioavailability of thymoquinone: optimization, characterization, pharmacokinetic, and hepatotoxicity studies. Drug Deliv Transl Res [Internet]. 2023;13(1):292–307. Available from:
. - 5. Sulaiman M, Lukitaningsih E, Martien R, Danarti R, Wirohadidjojo YW. Polymeric Nanoparticle Formulation, Characterization and Penetration Study for Topical Delivery of Timolol Maleate. J Turkish Chem Soc Sect A Chem. 2025;12(2):117–28.
- 6. Sharma K. Nanoemulgel Formulation of Tetrahydrocurcumin with Efficient Anti-inflammatory Effect for the Treatment of Skin Disorders. Indian J Pharm Educ Res [Internet]. 2023;57(3):528–39. Available from:
. - 7. Mah SH, Sundrasegaran S, Lau HLN. Topical Nanoemulsion Hydrogel Formulated from Supercritical Fluid Extracted Palm-Pressed Fiber Oil and Virgin Coconut Oil with Antioxidant and Antibacterial Effects. J Oleo Sci [Internet]. 2024;73(4):489–502. Available from:
. - 8. Hama AA, Aziz DM, Qader IN, Ibrahim BM, Meena BI. Nanocarriers for Controlled Drug Delivery A Convergence of Polymer and Nanochemistry. J Turkish Chem Soc Sect A Chem. 2024;11(4):1581–94.
Details
Primary Language
English
Subjects
Nanochemistry
Journal Section
Research Article
Authors
Rina Widiastuti
0009-0004-5669-4141
Indonesia
Akhmad Kharis Nugroho
*
0000-0003-4277-5413
Indonesia
Ronny Martien
0000-0001-7291-6497
Indonesia
Endang Lukitaningsih
0000-0002-4969-5128
Indonesia
Publication Date
April 30, 2026
Submission Date
September 19, 2025
Acceptance Date
April 12, 2026
Published in Issue
Year 2026 Number: 2026-1
